
MedLeanRx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: Texas-only compounded semaglutide priced from the starting dose, plus brand options
MedLeanRx scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
MedLeanRx is a physician-guided telehealth weight-loss clinic serving Texas only, based in Spring, TX. It prescribes compounded semaglutide as a weekly injection or daily oral tablet at $149/month and compounded tirzepatide at $269/month, plus a brand pathway for Wegovy, Zepbound, and Foundayo (orforglipron) at a $99/month fee with medication billed separately. A 5-minute online assessment gets a physician review in under 12 hours, with free shipping and cancel-anytime plans.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to MedLeanRx
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
MedLeanRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Oral Semaglutide Tablets, Brand Wegovy & Zepbound
- Starting price
- $149/mo (starting dose)
- What's included
- Medication · Consult · Shipping
- Availability
- 1 state
- FDA status
- No FDA warning letter on record
How we scored MedLeanRx
Each dimension is scored algorithmically from MedLeanRx’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.9/10At $149/mo (starting dose), MedLeanRx runs about 17% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
8.0/10MedLeanRx offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.2/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.1/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.4/10MedLeanRx operates in a limited 1-state footprint, so check availability first.
Support10%
5.7/10MedLeanRx provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this MedLeanRx review
Last checked October 2026- Confirmed current pricing across 3 dose/plan tiers
- Confirmed availability in 1 state
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $149–$269/mo across 3 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with MedLeanRx
We walked MedLeanRx’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Click Am I Qualified? or Start Your Free Assessment from any product card; the assessment page says it serves Texas only.
- 2Pick your primary goal (lose weight, manage weight, or improve overall health).
- 3Answer health questions, starting with sex and then pregnancy status, medical conditions, and medications (we stopped here).
- 4The form ends by asking for your state, name, email, and phone; a physician reviews it in under 12 hours, and approved medication ships to your door.
- Prices are on the product cards before you start: $149/mo semaglutide (injection or tablet), $269/mo tirzepatide, and $99/mo plus medication cost for brand options.
- The assessment is a free eligibility form with no payment step; you agree to the Terms by completing it.
- The limited-time Texas bundles ($325 tirzepatide, $300 semaglutide for 2 months) work the other way: pay first, then schedule a doctor consultation.
- FAQ says you can cancel anytime with no cancellation fees, but the Terms say all sales are final with no refunds.
- The homepage now promises physician review in under 12 hours, while the promotions page still says 24 to 48 hours.
- Contact page lists email support with hours Monday to Friday 9am to 6pm CT and Saturday 10am to 2pm CT.
MedLeanRx customer support
- Phone
- +1-855-520-1296
- Hours
- Mon-Fri 9am-6pm CT, Sat 10am-2pm CT
GLP-1 medications MedLeanRx offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Weekly semaglutide vial, $149/mo at the starting dose; the site says pricing may vary with dosage. 2-month intro bundle: $300 upfront for Texas clients.
Needle-free daily oral semaglutide tablets, $149/mo at the starting dose.
$269/mo standard. Intro bundle: 8 weeks at 2 mg weekly for one $325 payment (about $163/mo), Texas clients only, while supplies last.
Ready to get started?
Plans and promotions change often, so check MedLeanRx's current pricing and active discounts before you decide.
What we like
- Compounded semaglutide $149/mo in both weekly injection and daily oral tablet form
- Brand pathway for Wegovy, Zepbound, and Foundayo (orforglipron) at a $99/mo fee plus medication cost
- Intro bundle: 2 months of compounded tirzepatide (2 mg weekly) for $325, about $163/mo
- LegitScript seal displayed; named supervising physician (Dr. Johnson Uzor, MD)
- Free shipping, no hidden fees, and cancel anytime with no cancellation fees
- 5-minute online assessment with physician review in under 12 hours, 100% online
- Support by email with published weekday and Saturday hours
Watch-outs
- Texas only, not available in the other 49 states
- Compounded tirzepatide is $269/mo at standard pricing, above the ~$249 market median
- Strict no-refund policy: 'All sales are final' per Terms & Conditions
- Pharmacy partner not publicly named, a transparency gap for a compounding service
- Legal entity name and founding details not published on the site
- Brand-medication total cost not published: $99/mo fee plus the separate cost of medication
- Intro bundles are paid upfront before your doctor consultation, and payment doesn't guarantee a prescription
Is MedLeanRx worth it?
The short version of what MedLeanRx offers is Texas-only compounded semaglutide priced from the starting dose, plus brand options. It runs $149/month (starting dose); there's no clean category median to weigh that against, but it's a published number rather than one you find out only after signing up. Its standout is a needle-free oral option for people who would rather not inject.
Worth knowing before you sign up: MedLeanRx is LegitScript-certified.
How much MedLeanRx costs
Compounded semaglutide runs $149/month (starting dose) and compounded tirzepatide runs $269/month (starting dose).
Because MedLeanRx's headline figure is a starting dose, we don't set it against the roughly $179 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare MedLeanRx with the month-to-month prices of the alternatives below instead.
PlexusDx (about $149/month) is one of the closest alternatives to weigh MedLeanRx against.
Medications: what MedLeanRx prescribes
MedLeanRx prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two most-studied weight-loss molecules on the market today. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products, which is the standard trade-off across the compounded-GLP-1 market.
MedLeanRx's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who MedLeanRx is best for, and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
MedLeanRx is available in 1 state, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
MedLeanRx is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
The Bottom Line
MedLeanRx scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with MedLeanRx?
From $149/mo (starting dose). See current pricing and start your free consultation.
MedLeanRx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare MedLeanRx vs…
MedLeanRx scores7.2/10
Side-by-side pricing, medications and scores. Pick a matchup.
MedLeanRx vs Amazon One Medical
Amazon One Medical scores 8.5/10

MedLeanRx vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this MedLeanRx review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See MedLeanRx's current pricing
Plans from $149/mo (starting dose). Start your free consultation to check eligibility and today's price.